AstraZeneca and Bristol Myers Squibb have reportedly discussed a potential combination that could value the new group at nearly $400 billion. The talks remain preliminary, and neither company has announced a transaction. However, its scale and overlapping oncology portfolios matter
GSK announced a £400 million plan on July 28, 2026, to establish a 300,000-square-foot global R&D centre on the Cambridge Biomedical Campus. The company plans to move more than 1,000 UK scientists to Cambridge, leave its Stevenage R&D site through
